Leukocytes constitute the cellular components of the innate and adaptive immune system and are critical for host defense. These cells mediate acute and chronic inflammation, modulate immune responses, and protect the host against numerous pathogens.
Disorders affecting leukocytes can be divided broadly into malignant disorders (tumors of leukocytes or their progenitors) and non-malignant disorders.
The malignant disorders are uncommon but clinically important entities
Non- malignant leukocyte disorders can involve any any of the leukocytes (neutrophils, eosinophils, basophils, monocytes, B cells, T cells, and natural killer cells)
but the disorders of greatest clinical relevance affect neutrophils; these will be our major focus.
2. Leukocyte Disorders
• Leukocytes constitute the cellular components of the innate and
adaptive immune system and are critical for host defense. These
cells mediate acute and chronic inflammation, modulate immune
responses, and protect the host against numerous pathogens.
• Disorders affecting leukocytes can be divided broadly into
malignant disorders (tumors of leukocytes or their progenitors) and
non-malignant disorders.
• The malignant disorders are uncommon but clinically important
entities
• Non- malignant leukocyte disorders can involve any any of the
leukocytes (neutrophils, eosinophils, basophils, monocytes, B cells,
T cells, and natural killer cells)
• but the disorders of greatest clinical relevance affect neutrophils;
these will be our major focus.
4. WHAT HAPPENS IN BONE MARROW?
• Neutrophils, red cells and megakaryocytes all descended
from common precursor cell called myeloid stem cell
• Stem cells differentiate into primitive cells called blasts,
which are precursors of each cell type
• Blasts divide and mature under the influence of proteins
called growth factors; as they mature they lose the ability to
divide
• Mature neutrophils and red cells enter the blood
• Megakaryocytes break into small fragments (platelets),
which enter blood
6. Granules in Neutrophils: Primary granules: promyelocyte stage , Secondary granules: myelocyte stage and predominate therafter
Myelopoiesis
Myelopoiesis: As granulocytes develop and mature, they go through
a series of recognizable morphologic stages that correlate with the
expression of genes that confer the specific functions indicated on
the time line.
HSC, hematopoietic stem cell; PMN, polymorphonuclear leukocyte.
Life span of neutrophil in Blood is 6-10 hours
13. Polymorphonuclear Leukocytes
• Polymorphonuclear leukocytes, also called
granulocytes because their cytoplasm contains
granules, include
– Neutrophils
– Eosinophils
– Basophils
• Polymorphonuclear leukocytes occur in the
circulation and have multilobed nuclei.
15. Neutrophils
• Neutrophils constitute 40 to 70% of total circulating WBCs;
they are a first line of defense against infection. Mature
neutrophils have a half-life of about 2 to 3 days.
• During acute inflammatory responses (eg, to infection),
neutrophils, drawn by chemotactic factors and alerted by the
expression of adhesion molecules on blood vessel
endothelium, leave the circulation and enter tissues.
• Their purpose is to phagocytose and digest pathogens.
• Microorganisms are killed when phagocytosis generates lytic
enzymes and reactive oxygen compounds and triggers release
of granule contents.
16. Eosinophils
• Eosinophils are granulocytes derived from the same
progenitor cells as monocytes-macrophages,
neutrophils, and basophils. They are a component of
the innate immune system. Eosinophils have a
variety of functions, including
– Defense against parasitic infections
– Defense against intracellular bacteria
– Modulation of immediate hypersensitivity reactions
17. Eosinophils
• Eosinophils constitute up to 5% of circulating WBCs.
• They target organisms too large to be engulfed; they
kill by secreting toxic substances (eg, reactive oxygen
compounds similar to those produced in neutrophils),
major basic protein (which is toxic to parasites),
eosinophil cationic protein, and several enzymes.
• Eosinophils are also a major source of inflammatory
mediators (eg, prostaglandins, leukotrienes, platelet-
activating factor, many cytokines).
18. Eosinophil production and function
• Eosinophil production appears to be regulated by
T-Cells through the secretion of the hematopoietic
growth factors:
– granulocyte-macrophage colony-stimulating factor (GM-
CSF),
– interleukin-3 (IL-3), interleukin-5 (IL-5).
– Although GM-CSF and IL-3 also increase the production of
other myeloid cells, IL-5 increases eosinophil production
exclusively.
19. Eosinophil production and function
• Eosinophil granules contain major basic protein and
eosinophil cationic protein;
– toxic to several parasites and to mammalian cells.
– These proteins bind heparin and neutralize its anticoagulant
activity.
• Eosinophil-derived neurotoxin can severely damage
myelinated neurons.
• Eosinophil peroxidase, generates oxidizing radicals in
the presence of hydrogen peroxide and a halide.
– Charcot-Leyden crystals are primarily composed of
phospholipase B and are located in sputum, tissues, and stool
in disorders in which there is eosinophilia
(eg, asthma, eosinophilic pneumonia).
20. Normal peripheral blood
eosinophil count
• Diurnal levels vary inversely with plasma cortisol levels;
the peak occurs at night and the trough in the morning.
• The eosinophil count can decrease with stress, with the
use of beta-blockers or corticosteroids, and sometimes
during bacterial or viral infections.
• The count can increase (eosinophilia) in allergic
disorders, during certain infections (typically parasitic),
and as a result of numerous other causes.
• The circulating half-life of eosinophils is 6 to 12 h, with
most eosinophils residing in tissues (eg, the upper
respiratory tract, GI tract, skin, uterus).
21. Normal peripheral blood
eosinophil count
• Generally accepted that a count > 500/mcL is
elevated.
• Peripheral eosinophilia is characterized as
– Mild: 500 to 1500/mcL
– Moderate: 1500 to 5000/mcL
– Severe: > 5000/mcL
22. Basophils
• Basophils constitute < 5% of circulating WBCs and
share several characteristics with mast cells
• Both have high-affinity receptors for IgE called Fc-
epsilon RI (FcεRI).
• When these cells encounter certain antigens, the
bivalent IgE molecules bound to the receptors become
cross-linked, triggering cell degranulation with release
of preformed inflammatory mediators (eg, histamine,
platelet-activating factor) and generation of newly
synthesized mediators (eg, leukotrienes,
prostaglandins, thromboxanes).
23. Monocytes
• Monocytes in the circulation are precursors to tissue
macrophages.
• Monocytes migrate into tissues, where over about 8 h,
they develop into macrophages under the influence of
macrophage colony-stimulating factor (M-CSF),
secreted by various cell types (eg, endothelial cells,
fibroblasts).
• At infection sites, activated T cells secrete cytokines
(eg, interferon-gamma [IFN-gamma]) that induce
production of macrophage migration inhibitory factor,
preventing macrophages from leaving.
24. Macrophages
• Macrophages are activated by IFN-gamma and
granulocyte-macrophage colony-stimulating factor
(GM-CSF).
• Activated macrophages kill intracellular organisms and
secrete IL-1 and tumor necrosis factor-alpha (TNF-
alpha).
• These cytokines potentiate the secretion of IFN-gamma
and GM-CSF and increase the expression of adhesion
molecules on endothelial cells, facilitating leukocyte
influx and destruction of pathogens.
• Based on different gene expression profiles, subtypes
of macrophages (eg, M1, M2) have been identified.
25. Lymphocytes
• The 2 main types of lymphocytes are
– B cells (which mature in bone marrow)
– T cells (which mature in the thymus)
• They are morphologically indistinguishable but have
different immune functions.
• They can be distinguished by antigen-specific surface
receptors and molecules called clusters of
differentiation (CDs), whose presence and absence
define some subsets.
• More than 300 CDs have been identified
• Each lymphocyte recognizes a specific antigen via
surface receptors.
26. B cells
• About 5 to 15% of lymphocytes in the blood are B
cells; they are also present in the bone marrow,
spleen, lymph nodes, and mucosa-associated
lymphoid tissues.
• B cells can present antigen to T cells and release
cytokines, but their primary function is to
develop into plasma cells, which manufacture
and secrete antibodies.
• Patients with B-cell immunodeficiencies (eg, X-
linked agammaglobulinemia) are especially
susceptible to recurrent bacterial infections.
27. T cells
• T cells develop from bone marrow stem cells
that travel to the thymus, where they go
through rigorous selection. There are 3 main
types of T cell:
• Helper
• Regulatory (suppressor)
• Cytotoxic
28. Helper T (Th) cells
• Helper T (Th) cells are usually CD4 but may be CD8. They
differentiate from Th0 cells into one of the following:
• Th1 cells: In general, Th1 cells promote cell-mediated
immunity via cytotoxic T cells and macrophages and are
thus particularly involved in defense against intracellular
pathogens (eg, viruses). They can also promote the
production of some antibody classes.
• Th2 cells: Th2 cells are particularly adept at promoting
antibody production by B cells (humoral immunity) and
thus are particularly involved in directing responses aimed
at extracellular pathogens (eg, bacteria, parasites).
• Th17 cells: Th17 cells promote tissue inflammation.
29. Regulatory (suppressor) T cells
• Regulatory (suppressor) T cells mediate suppression of
immune responses and usually express the Foxp3
transcription factor.
• The process involves functional subsets of CD4 or CD8
T cells that either secrete cytokines with
immunosuppressive properties or suppress the
immune response by poorly defined mechanisms that
require cell-to-cell contact.
• Patients with functional mutations in Foxp3 develop
the autoimmune disorder IPEX
syndrome (immunodysregulation, polyendocrinopathy,
enteropathy, X-linked syndrome).
30. Cytotoxic T (Tc) cells
• Cytotoxic T (Tc) cells are usually CD8 but may be CD4; they
are vital for eliminating intracellular pathogens, especially
viruses. Tc cells play a role in organ transplant rejection.
• Tc-cell development involves 3 phases:
• A precursor cell that, when appropriately stimulated, can
differentiate into a Tc cell
• An effector cell that has differentiated and can kill its
appropriate target
• A memory cell that is quiescent (no longer stimulated) but
is ready to become an effector when restimulated by the
original antigen-MHC combination
• Fully activated Tc cells, like NK cells, can kill an infected
target cell by inducing apoptosis.
31. Mast Cells
• Mast cells are tissue-based and functionally similar to
basophils circulating in the blood.
• Mucosal mast cell granules contain tryptase and
chondroitin sulfate; connective tissue mast cell
granules contain tryptase, chymase, and heparin. By
releasing these mediators, mast cells play a key role in
generating protective acute inflammatory responses;
basophils and mast cells are the source of type I
hypersensitivity reactions associated with atopic
allergy. Degranulation can be triggered by cross-linking
of IgE receptors or by the anaphylatoxin complement
fragments C3a and C5a.
32. Definitions White Cell Numbers
• Leukocytosis: increase in the numbers of circulating white
cells: >12,000/uL
• Leukopenia: decrease in the numbers of circulating white
cells: < 4,000/uL
• Left Shift – increased circulating numbers of immature
neutrophils
• Leukoerythroblastic Reaction – leukocytosis with a left
shift accompanied by nucleated red cells: seen in
malignancy.
• Leukemoid Reaction – benign excessive leukocytosis
accompanied by an exaggerated neutrophilia and a left
shift in response to an infection; the WBC > 50 x 109/L
33. Definitions White Cell Numbers
• Neutrophilia >7.5 x 109/L
• Other defining features:
– Left shift – Increased band forms
– “toxic” cell appearance
• Dohle bodies
• Vacuoles
• Intra-cellular microbes
40. Infectious Mononucleosis
• Acute, self-limiting, febrile infection of B-cells
• Circulating reactive lymphocytes are primary CD8 T-cells
• Typically occurs in those age 10-25 years
– Fever
– Sore throat
– Lymphadenopathy
– Lethargy
Positive serology
Heterophile antibodies
41. Leukopenia
• is a reduction in the circulating WBC count to < 4000/μL. It is usually
characterized by a reduced number of circulating neutrophils, although a
reduced number of lymphocytes, monocytes, eosinophils, or basophils
may also contribute. Thus, immune function can be generally decreased.
• Neutropenia is a reduction in blood neutrophil count to < 1500/μL in
whites and < 1200/ÎĽL in blacks. It is sometimes accompanied by
monocytopenia and lymphocytopenia, which cause additional immune
deficits.
• Lymphocytopenia, in which the total number of lymphocytes is < 1000/μL
in adults, is not always recognized as a decrease in the total WBC count
because lymphocytes account for only 20 to 40% of the total WBC count.
The consequences of the lymphopenia can depend on the lymphocyte
subpopulation(s) that are decreased.
• Monocytopenia is a reduction in blood monocyte count to < 500/μL.
Monocytes migrate into the tissues where they become macrophages,
with specific characteristics depending on their tissue localization.
42. Neutropenia
Neutropenia < 1.5 x 109/L
Definition: less than the normal absolute count; greatly
influenced by patient age and race. African and Middle Eastern
populations Subclasses include mild, moderate and severe:
• Reactions to Drugs
• BM ablative therapy
• Infections
• HIV/Hepatitis
• Typhoid/ miliary TB
• Malaria
• Immune Disorders
• Systemic lupus erythromatous (SLE)
• Neoplasm
• BM Failure
• Megaloblastic Anemia
• Aplastic Anemia
• Hypersplenism
• Idiopathic (of unknown cause).
Causes
43. Neutropenia
• Neutropenia is absolute neutrophil count (ANC)
<1500 cells/microL
• Severe neutropenia is ANC <500/µL, or an ANC
that is expected to decrease to <500/µL over the
next 48 hours
ANC= WBC x (PMN % + Bands %)
Aşkın K. KAPLAN M.D.
44. Eosinopenia
• Eosinopenia is a form of agranulocytosis where the
number of eosinophil granulocytes in perepheral
blood is lower than expected < 40/cmm
– Bacterial infection
– By stress reactions
– Cushing's syndrome
– By the use of steroids
– Pathological causes include burns and acuteinfections.
45. Neutropenic Fever
• The Infectious Diseases Society of America
defines neutropenic fever as
– a single oral temperature of >38.3°C (101°F) or
– a temperature of >38.0°C (100.4°F) sustained for
>1 hour
Aşkın K. KAPLAN M.D.
46. Neutropenia Causes
• Defects inside or outside the Bone Marrow
– Decreased proliferation [failure of cells - aplasia]
– Decreased maturation [insufficient number of
precursors undergoing abnormal maturation]
– Decreased survival [increased destruction and/or
rapid removal of cells]
– Distribution [total body pools are normal,
circulating numbers are reduced]
47. Lymphopenia
• Lymphopenia Absolute lymphocyte count <0.6
x 109/L
• There are three types of abnormalities:
– Decreased production
– Increased destruction
– Changes in distribution
49. Monocytopenia
• is a reduction in blood monocyte count
to < 500/ÎĽL. Risk of certain infections is
increased. It is diagnosed by CBC with
differential. Treatment with hematopoietic
stem cell transplantation may be needed.
53. Pelger Huet vs band neutrophil
•Pelger Huet – an inherited condition
resulting in hyposegmentation of
granulocyte nuclei with increased density
and coarseness of the chromatin.. Don’t
confuse this anomaly with a neutrophilic
left shift!
•May-Hegglin - a rare syndrome
characterized by leukopenia, variable
thrombocytopenia, GIANT PLATELETS, and
gray-blue cytoplasmic inclusions in the
neutrophils and monocytes [dohle-like
bodies]
54. Alder-Reilly vs Chediak-Higashi
• Alder-Reilly - an inherited trait characterized
by the presence of abnormally large
azurophilic and basophilic granules
resembling neutrophilic toxic granulation.
• Chediak-Higashi - is a genetic disorder that
has an equivalent syndrome in mink, cattle,
mice, cats, & killer whales. Affected
individuals display partial albinism, are very
susceptible to common infectious agents, and
have white cells demonstrating giant
cytoplasmic granules.
55. Definitions
• Gaucher & Niemann-Pick are characterized by the lack of or
defective activity of enzymes.
• In Gaucher disease, there is a lack of beta-glucocerebrosidase
and macrophages become laden with glucocerebrosides.
• In Niemann-Pick, there is deficient activity of lysosomal
hydrolase and sphingomyelinase resulting in the accumulation
of cholesterol and sphingomyelin in mononuclear phagocytes.
• Mucopolysaccharidoses are a group of genetically determined
deficiencies of specific enzymes involved in the degradation of
mucopolysaccharides. Examples: Hurlers, Hunter, Sanfilippo
56. Pelger-Huet & Hypersegmentation
Bilobed and occasional
unsegmented neutrophils
Autosomal recessive disorder
Rare autosomal dominant condition
Neutrophil function is essentially normal
Pelger-Huet anomaly Neutrophil hyper-segmentation
57. May Hegglin
Neutrophils contain basophilic inclusions of RNA
Occasionally there is associated leucopenia, Thrombocytopenia
and giant platelet are frequent.
59. Chediak Higashi
Autosomal recessive disorder
Giant granules in granulocytes, monocytes and lymphocytes
Partial occulocutaneous albinism, Depressed migration and degranulation ,
Recurrent pyogenic infections , Lymphoproliferative syndrome may develop
Treatment is BMT
BMT Bone Marrow Transplant
62. Dohle Bodies and Necrobiosis
Necrobiotic WBC displays nuclear
degradation or karyorrhexis. Indicates
cell death in chemotherapy or a poorly
preserved specimen.
Single or multiple blue cytoplasmic
inclusions. They represent remnants of
rough endoplasmic reticulum from earlier
maturational stages.
They are associated with myeloid "left
shifts" and are seen in conjunction with
toxic granulation.
Mature blood cells differentiate from pluripotent hematopoietic stem cells. The differentiation of mature blood cells from hematopoietic stem cells represents a continuous process that involves discrete changes triggered by the surrounding micro environment and cumulative signals from soluble glycoprotein factors.
The signals that stimulate mature blood cell production and signals that act to prevent the overproduction of blood cells are carefully balanced to supply the quantity of blood cells necessary for life. Not all of the regulatory processes are fully understood. Early progenitor cells, such as the colony-forming-unit granulocyte, erythrocyte, macrophage, megakaryocyte (CFU-GEMM), are able to differentiate into multiple lineages but are unable to reconstitute the entire hematopoietic system when transplanted into an irradiated host.
Life span of neutrophil
in Blood is 6-10 hours
Neutrophils constitute 40 to 70% of total circulating WBCs; they are a first line of defense against infection. Mature neutrophils have a half-life of about 2 to 3 days.
During acute inflammatory responses (eg, to infection), neutrophils, drawn by chemotactic factors and alerted by the expression of adhesion molecules on blood vessel endothelium, leave the circulation and enter tissues.
Their purpose is to phagocytose and digest pathogens.
Microorganisms are killed when phagocytosis generates lytic enzymes and reactive oxygen compounds (eg, superoxide, hypochlorous acid) and triggers release of granule contents (eg, defensins, proteases, bactericidal permeability-increasing protein, lactoferrin, lysozymes).
DNA and histones are also released, and they, with granule contents such as elastase, generate fibrous structures called neutrophil extracellular traps (NETs) in the surrounding tissues; these structures facilitate killing by trapping bacteria and focusing enzyme activity.
Patients with immunodeficiencies that affect the phagocytes' ability to kill pathogens (eg, chronic granulomatous disease) are especially susceptible to chronic bacterial and fungal infections.
Eosinophils are especially important in defense against parasitic infections. However, although eosinophilia commonly accompanies helminthic infections and eosinophils are toxic to helminths in vitro, there is no direct evidence that they kill parasites in vivo.
Although they are phagocytic, eosinophils are less efficient than neutrophils in killing intracellular bacteria.
Eosinophils may modulate immediate hypersensitivity reactions by degrading or inactivating mediators released by mast cells, such as histamine, leukotrienes (which may cause vasoconstriction and bronchoconstriction), lysophospholipids, and heparin.
Prolonged eosinophilia may result in tissue damage by mechanisms that are not fully understood.
Eosinophil production appears to be regulated by T cells through the secretion of the hematopoietic growth factors granulocyte-macrophage colony-stimulating factor (GM-CSF), interleukin-3 (IL-3), and interleukin-5 (IL-5). Although GM-CSF and IL-3 also increase the production of other myeloid cells, IL-5 increases eosinophil production exclusively.
Eosinophil granules contain major basic protein and eosinophil cationic protein; these proteins are toxic to several parasites and to mammalian cells. These proteins bind heparin and neutralize its anticoagulant activity. Eosinophil-derived neurotoxin can severely damage myelinated neurons. Eosinophil peroxidase, which differs significantly from peroxidase of other granulocytes, generates oxidizing radicals in the presence of hydrogen peroxide and a halide. Charcot-Leyden crystals are primarily composed of phospholipase B and are located in sputum, tissues, and stool in disorders in which there is eosinophilia (eg, asthma, eosinophilic pneumonia).
Eosinophil production appears to be regulated by T cells through the secretion of the hematopoietic growth factors granulocyte-macrophage colony-stimulating factor (GM-CSF), interleukin-3 (IL-3), and interleukin-5 (IL-5). Although GM-CSF and IL-3 also increase the production of other myeloid cells, IL-5 increases eosinophil production exclusively.
Eosinophil granules contain major basic protein and eosinophil cationic protein; these proteins are toxic to several parasites and to mammalian cells. These proteins bind heparin and neutralize its anticoagulant activity. Eosinophil-derived neurotoxin can severely damage myelinated neurons. Eosinophil peroxidase, which differs significantly from peroxidase of other granulocytes, generates oxidizing radicals in the presence of hydrogen peroxide and a halide. Charcot-Leyden crystals are primarily composed of phospholipase B and are located in sputum, tissues, and stool in disorders in which there is eosinophilia (eg, asthma, eosinophilic pneumonia).
Diurnal levels vary inversely with plasma cortisol levels; the peak occurs at night and the trough in the morning.
The eosinophil count can decrease with stress, with the use of beta-blockers or corticosteroids, and sometimes during bacterial or viral infections.
The count can increase (eosinophilia) in allergic disorders, during certain infections (typically parasitic), and as a result of numerous other causes.
The circulating half-life of eosinophils is 6 to 12 h, with most eosinophils residing in tissues (eg, the upper respiratory tract, GI tract, skin, uterus).
Breaching of anatomic barriers can trigger 2 types of immune response:
Innate
Acquired
Many molecular components (eg, complement, cytokines, acute phase proteins) participate in both innate and acquired immunity.
Innate immunity
Innate (natural) immunity does not require prior exposure to an antigen (ie, immunologic memory) to be effective. Thus, it can respond immediately to an invader. Innate immunity recognizes mainly antigen molecules that are broadly distributed rather than specific to one organism or cell.
Components include
Phagocytic cells
Innate lymphoid cells (eg, natural killer [NK] cells)
Polymorphonuclear leukocytes
Diurnal levels vary inversely with plasma cortisol levels; the peak occurs at night and the trough in the morning.
The eosinophil count can decrease with stress, with the use of beta-blockers or corticosteroids, and sometimes during bacterial or viral infections.
The count can increase (eosinophilia) in allergic disorders, during certain infections (typically parasitic), and as a result of numerous other causes.
The circulating half-life of eosinophils is 6 to 12 h, with most eosinophils residing in tissues (eg, the upper respiratory tract, GI tract, skin, uterus).
Breaching of anatomic barriers can trigger 2 types of immune response:
Innate
Acquired
Many molecular components (eg, complement, cytokines, acute phase proteins) participate in both innate and acquired immunity.
Innate immunity
Innate (natural) immunity does not require prior exposure to an antigen (ie, immunologic memory) to be effective. Thus, it can respond immediately to an invader. Innate immunity recognizes mainly antigen molecules that are broadly distributed rather than specific to one organism or cell.
Components include
Phagocytic cells
Innate lymphoid cells (eg, natural killer [NK] cells)
Polymorphonuclear leukocytes
After random rearrangement of the genes that encode immunoglobulin (Ig), B cells collectively have the potential to recognize an almost limitless number of unique antigens. Gene rearrangement occurs in programmed steps in the bone marrow during B-cell development. The process starts with a committed stem cell, continues through pro‒B and pre‒B cell stages, and results in an immature B cell. At this point, any cells that interact with self antigen (autoimmune cells) are removed from the immature B cell population via inactivation or apoptosis (immune tolerance). Cells that are not removed (ie, those that recognize nonself antigen) continue to develop into mature naive B cells, leave the marrow, and enter peripheral lymphoid organs, where they may encounter antigens.
Their response to antigen has 2 stages:
Primary immune response:Â When mature naive B cells first encounter antigen, they become lymphoblasts, undergo clonal proliferation, and differentiate into memory cells, which can respond to the same antigen in the future, or into mature antibody-secreting plasma cells. After first exposure, there is a latent period of days before antibody is produced. Then, only IgM is produced. After that, with the help of T cells, B cells can further rearrange their Ig genes and switch to production of IgG, IgA, or IgE. Thus, after first exposure, the response is slow and provides limited protective immunity.
Secondary (anamnestic or booster) immune response: When memory B and Th cells are reexposed to the antigen, the memory B cells rapidly proliferate, differentiate into mature plasma cells, and promptly produce large amounts of antibody (chiefly IgG because of a T cell–induced isotype switch). The antibody is released into the blood and other tissues, where it can react with antigen. Thus, after reexposure, the immune response is faster and more effective.
In selection, T cells that react to self antigen presented by self MHC molecules or to self MHC molecules (regardless of the antigen presented) are eliminated by apoptosis. Only T cells that can recognize nonself antigen complexed to self MHC molecules survive; they leave the thymus for peripheral blood and lymphoid tissues.
Most mature T cells express either CD4 or CD8 and have an antigen-binding, Ig-like surface receptor called the T-cell receptor (TCR). There are 2 types of TCR:
Alpha-beta TCR: Composed of TCR alpha and beta chains; present on most T cells
Gamma-delta TCR: Composed of TCR gamma and delta chains; present on a small population of T cells
Genes that encode the TCR, like Ig genes, are rearranged, resulting in defined specificity and affinity for antigen. Most T cells (those with an alpha-beta TCR) recognise antigen-derived peptide displayed in the MHC molecule of an antigen-presenting cell. Gamma-delta T cells recognize protein antigen directly or recognize lipid antigen displayed by an MHC-like molecule called CD1. As for B cells, the number of T-cell specificities is almost limitless.
For alpha-beta T cells to be activated, the TCR must engage with antigen-MHC (see figure Two-signal model for T cell activation). Costimulatory accessory molecules must also interact (eg, CD28 on the T cell interacts with CD80 and CD86 on the antigen-presenting cell); otherwise, the T cell becomes anergic or dies by apoptosis. Some accessory molecules (eg, CTLA-4 on the T cell, which also interacts with CD80 and CD86 on the antigen-presenting cell, PD-1 on the T cell, which interacts with PD-L1 on the antigen-presenting cell) inhibit previously activated T cells and thus dampen the immune response. Molecules such as CTLA-4 and PD-1, and their ligands, are termed checkpoint molecules because they signal that the T cell needs to be restrained from continuing its activity. Cancer cells that express checkpoint molecules may thus be protected from the immune system by restraining the activity of tumor-specific T cells.
Monoclonal antibodies that target checkpoint molecules on either T cells or on tumor cells (termed checkpoint inhibitors, see table Some Immunotherapeutic Agents in Clinical Use) are used to prevent downregulation of antitumor responses and effectively treat some heretofore resistant cancers. However, because checkpoint molecules are also involved in other types of immune response, checkpoint inhibitors can cause severe immune-related inflammatory and autoimmune reactions (both systemic and organ specific).
Polymorphisms in the CTLA-4 gene are associated with certain autoimmune disorders, including Graves disease and type I diabetes.
Tc cells can secrete cytokines and, like Th cells, have been divided into types Tc1 and Tc2 based on their patterns of cytokine production.
Tc cells may be
Syngeneic: Generated in response to self (autologous) cells modified by viral infection or other foreign proteins
Allogeneic: Generated in response to cells that express foreign MHC products (eg, in organ transplantation when the donor’s MHC molecules differ from the recipient’s)
Some Tc cells can directly recognize foreign MHC (direct pathway); others may recognize fragments of foreign MHC presented by self MHC molecules of the transplant recipient (indirect pathway).
In all cancer patients presenting with neutropenic fever, empiric antibacterial therapy should be initiated immediately after blood cultures have been obtained and before any other investigations have been completed.
Monocytes migrate into the tissues where they become macrophages, with specific characteristics depending on their tissue localization.
Monocytopenia can increase the risk of infection, and it can indicate poor prognosis in patients with acetaminophen-induced hepatic damage and thermal injuries. Peripheral blood monocytopenia does not usually indicate a decrease in tissue macrophages; in some cases it can be associated with impaired granuloma formation in response to infections.
Monocytopenia can result from
Chemotherapy-induced myelosuppression (along with other cytopenias)
Hematopoietic cell mutation involving GATA2
Neoplastic disorders (eg, hairy cell leukemia, acute lymphoblastic leukemia, Hodgkin lymphoma)
Infections (eg, HIV infection, Epstein-Barr virus infection, adenovirus infection, miliary tuberculosis)
Corticosteroid or immunoglobulin therapy
Gastric or intestinal resection
Transient monocytopenia can occur with endotoxemia, hemodialysis, or cyclic neutropenia.
Monocytopenia due to GATA2 mutation
A severe deficiency or absence of monocytes can occur in patients with mutations of the hematopoietic transcription factor gene, GATA2. Dendritic cells are decreased, and there may also be lymphocytopenia (mainly natural killer and B cells).
Despite near-absence of circulating monocytes, tissue macrophages are usually preserved. Also, immunoglobulin levels are usually normal even when circulating B cells are depressed. Bone marrow is hypocellular and can show fibrosis and multilineage dysplasia. Karyotypic abnormalities, including monosomy 7 and trisomy 8, may be present.
Infections with Mycobacterium avium complex (MAC) or other nontuberculous mycobacterial infections are common (MonoMAC syndrome). Fungal infections (ie, histoplasmosis, aspergillosis) also are typical. Infections with human papillomavirus (HPV) may occur with subsequent risk of progression to secondary cancers. There is a high risk of progression to hematologic disorders (myelodysplasia, acute myelogenous leukemia, chronic myelomonocytic leukemia, lymphomas) with a resulting poor prognosis.
Unvaccinated patients should be given HPV vaccination. Any infections are treated with appropriate antimicrobials. Allogeneic hematopoietic stem cell transplantation should be considered for symptomatic patients.